We are live on ! Find out more
BM

Bridger Management Portfolio holdings

AUM $128M
1-Year Est. Return 9.54%
This Fund
S&P 500
This Quarter Est. Return
+0.86%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.27B
AUM Growth
+$10.6M
Cap. Flow
+$22.3M
Cap. Flow %
1.75%
Top 10 Hldgs %
51.69%
Holding
39
New
6
Increased
9
Reduced
11
Closed
8

Top Buys

Rank Stock Value
1
ALC icon
Alcon
ALC
+$70.5M
2
HUM icon
Humana
HUM
+$68.8M
3
HCA icon
HCA Healthcare
HCA
+$47.3M
4
ZGNX
Zogenix, Inc.
ZGNX
+$30M
5
LKQ icon
LKQ Corp
LKQ
+$25.1M

Top Sells

Rank Stock Value
1
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$56.6M
2
LH icon
Labcorp
LH
+$50.6M
3
WMGI
Wright Medical Group Inc
WMGI
+$44.8M
4
VSAT icon
Viasat
VSAT
+$37.2M
5
STAA icon
STAAR Surgical
STAA
+$17.6M

Sector Composition

Rank Sector Weight
1 Healthcare 44.59%
2 Consumer Discretionary 13.16%
3 Technology 12.9%
4 Communication Services 7.05%
5 Consumer Staples 4.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDCO
1
DELISTED
Medicines Co
MDCO
$84.4M 6.62%
2,314,014
-527,747
-19% -$17.2M
GDDY icon
2
GoDaddy
GDDY
$10.5B
$80M 6.28%
1,140,745
+83,845
+8% +$6.32M
ALC icon
3
Alcon
ALC
$33.4B
$74.5M 5.85%
+1,200,916
New +$70.5M
HUM icon
4
Humana
HUM
$44.5B
$71.9M 5.65%
+271,178
New +$68.8M
DRNA
5
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$65.7M 5.16%
4,171,065
-602,653
-13% -$8.19M
POST icon
6
Post Holdings
POST
$4.18B
$62.3M 4.89%
915,185
– –
CHTR icon
7
Charter Communications
CHTR
$17.3B
$58.3M 4.58%
147,619
-23,832
-14% -$8.93M
MS icon
8
Morgan Stanley
MS
$334B
$55.4M 4.35%
1,264,488
– –
CZR icon
9
Caesars Entertainment
CZR
$6.05B
$53.1M 4.17%
1,151,892
+405,394
+54% +$19.9M
HRTX icon
10
Heron Therapeutics
HRTX
$93.9M
$52.9M 4.15%
2,846,555
+810,356
+40% +$16.2M
HCA icon
11
HCA Healthcare
HCA
$86.1B
$50.6M 3.97%
+374,397
New +$47.3M
GDS icon
12
GDS Holdings
GDS
$6.46B
$48.2M 3.78%
1,282,677
+176,957
+16% +$6.44M
ALNY icon
13
Alnylam Pharmaceuticals
ALNY
$27.3B
$45.5M 3.57%
626,716
+4,266
+0.7% +$327K
SHAK icon
14
Shake Shack
SHAK
$2.55B
$41M 3.22%
568,181
+50,000
+10% +$3.09M
NKTR icon
15
Nektar Therapeutics
NKTR
$2.37B
$38.6M 3.03%
72,240
-10,326
-13% -$5.18M
MGM icon
16
MGM Resorts International
MGM
$11.4B
$38.2M 3%
1,338,061
-430,768
-24% -$11.5M
CNC icon
17
Centene
CNC
$30.6B
$37.7M 2.96%
719,206
+347,423
+93% +$18.8M
VRSN icon
18
VeriSign
VRSN
$26.1B
$36.1M 2.83%
172,604
-30,356
-15% -$5.96M
ZGNX
19
DELISTED
Zogenix, Inc.
ZGNX
$35.6M 2.8%
+745,667
New +$30M
ATRA icon
20
Atara Biotherapeutics
ATRA
$72.5M
$34.6M 2.71%
68,786
-1,322
-2% -$933K
LBRDA icon
21
Liberty Broadband Class A
LBRDA
$4.88B
$31.4M 2.47%
305,535
-84,757
-22% -$8.32M
TGTX icon
22
TG Therapeutics
TGTX
$8B
$29.5M 2.32%
3,414,668
-588,813
-15% -$4.45M
LKQ icon
23
LKQ Corp
LKQ
$5.69B
$23.8M 1.87%
+894,863
New +$25.1M
RCKT icon
24
Rocket Pharmaceuticals
RCKT
$336M
$18.7M 1.47%
1,247,366
-281,666
-18% -$4.92M
ZBH icon
25
Zimmer Biomet
ZBH
$18B
$17.9M 1.41%
156,914
-65,148
-29% -$7.63M
1
2

Similar funds

SHFC
Safe Harbor Family Capital Chapel Hill, North Carolina $128M AUM
IUC
Ivory Union Consulting Road Town $128M AUM
PC
Pelham Capital London, United Kingdom $128M AUM 34.73% 1-Year Est. Return
SIM
Summitas Investment Management Mckinney, Texas $128M AUM
PIA
Prakash Investment Advisors Andover, Massachusetts $128M AUM 44.06% 1-Year Est. Return
S
Storgate Dallas, Texas $127M AUM
CF
Concorde Financial Dallas, Texas $127M AUM 24.97% 1-Year Est. Return
BC
Barnett & Company Chattanooga, Tennessee $129M AUM 14.9% 1-Year Est. Return

Bridger Management's Q2 2019 Portfolio in Review

As of Q2 2019, Bridger Management held 39 positions worth $1.27B, up 0.84% from $1.26B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Bridger Management's Q2 2019 filing shows 6 new, 9 increased, 11 reduced and 8 closed positions. Its largest new stake was Alcon: 1,200,916 shares worth $74.5M. The largest sale was Ironwood Pharmaceuticals, an estimated $56.6M.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 44% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Bridger Management's largest Q2 2019 buy was Alcon: 1,200,916 shares worth $74.5M.
  • Bridger Management added most to Caesars Entertainment in Q2 2019, an estimated $19.9M increase.
  • Bridger Management's biggest Q2 2019 reduction was Medicines Co, cutting an estimated $17.2M.
  • Bridger Management fully exited Ironwood Pharmaceuticals in Q2 2019, selling an estimated $56.6M.
  • Bridger Management's ten largest holdings make up 52% of its $1.27B portfolio in Q2 2019.
  • Bridger Management opened 6 new positions and closed 8 in Q2 2019.
  • Bridger Management's portfolio value rose 0.84% quarter-over-quarter to $1.27B.

Based on Bridger Management's 13F filing for Q2 2019, filed 14 Aug 2019.